Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

about

Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress.Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.

P2860

Q52688054-9F046B20-C76B-4EFB-8E7E-EC016F59081E Q55257291-9B4495B7-949C-4354-B1E7-417646D692CD

P2860

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q47137783

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@en

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@nl

type

Item

label

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@en

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@nl

prefLabel

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@en

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@nl

P1476

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

@en

P2093

Jose A Santiago

http://www.w3.org/2001/XMLSchema#string

Judith A Potashkin

http://www.w3.org/2001/XMLSchema#string

Virginie Bottero

http://www.w3.org/2001/XMLSchema#string

P2860

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases

The associations between Parkinson's disease and cancer: the plot thickens

Parkinson's disease, insulin resistance and novel agents of neuroprotection

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Staging of brain pathology related to sporadic Parkinson's disease

Parkinsonism: onset, progression and mortality

Parkinson's disease

The role of dopamine in the pathophysiology of depression

Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies

P304

394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FNAGI.2017.00394

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29255414

http://www.w3.org/2001/XMLSchema#string

P932

5722846

http://www.w3.org/2001/XMLSchema#string

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

about

P2860

P2860

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932